Swiss National Bank grew its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 2.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,343,832 shares of the medical research company’s stock after acquiring an additional 34,400 shares during the period. Swiss National Bank’s holdings in Thermo Fisher Scientific were worth $367,834,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Norinchukin Bank The grew its position in shares of Thermo Fisher Scientific by 3.6% during the 1st quarter. Norinchukin Bank The now owns 76,407 shares of the medical research company’s stock worth $20,914,000 after buying an additional 2,671 shares during the period. Wellington Shields Capital Management LLC grew its holdings in Thermo Fisher Scientific by 2.8% during the first quarter. Wellington Shields Capital Management LLC now owns 13,440 shares of the medical research company’s stock valued at $3,679,000 after purchasing an additional 360 shares during the period. Northwestern Mutual Wealth Management Co. grew its holdings in Thermo Fisher Scientific by 5.4% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 72,354 shares of the medical research company’s stock valued at $19,806,000 after purchasing an additional 3,711 shares during the period. Northwestern Mutual Investment Management Company LLC grew its holdings in Thermo Fisher Scientific by 0.8% during the first quarter. Northwestern Mutual Investment Management Company LLC now owns 61,173 shares of the medical research company’s stock valued at $16,744,000 after purchasing an additional 494 shares during the period. Finally, Intact Investment Management Inc. grew its holdings in Thermo Fisher Scientific by 5.0% during the first quarter. Intact Investment Management Inc. now owns 2,100 shares of the medical research company’s stock valued at $575,000 after purchasing an additional 100 shares during the period. 87.96% of the stock is owned by institutional investors.

TMO has been the subject of a number of analyst reports. UBS Group boosted their price objective on shares of Thermo Fisher Scientific to $305.00 and gave the company a “buy” rating in a report on Monday, March 25th. BTIG Research boosted their price objective on shares of Thermo Fisher Scientific to $320.00 and gave the company a “buy” rating in a report on Thursday, May 23rd. Barclays boosted their price objective on shares of Thermo Fisher Scientific from $295.00 to $300.00 and gave the company an “overweight” rating in a report on Monday, March 18th. Bank of America restated a “buy” rating and set a $300.00 price objective (up previously from $285.00) on shares of Thermo Fisher Scientific in a report on Tuesday, April 16th. Finally, Deutsche Bank boosted their price objective on shares of Thermo Fisher Scientific from $275.00 to $300.00 and gave the company a “buy” rating in a report on Friday, March 22nd. Two analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $295.92.

In other news, Director C Martin Harris sold 275 shares of the company’s stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $270.73, for a total value of $74,450.75. Following the completion of the transaction, the director now owns 6,433 shares in the company, valued at $1,741,606.09. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Stephen Williamson sold 2,500 shares of the company’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $268.29, for a total transaction of $670,725.00. Following the completion of the transaction, the chief financial officer now owns 40,029 shares of the company’s stock, valued at approximately $10,739,380.41. The disclosure for this sale can be found here. Insiders sold 53,488 shares of company stock valued at $14,600,474 in the last quarter. Corporate insiders own 0.45% of the company’s stock.

Shares of Thermo Fisher Scientific stock traded down $1.44 on Wednesday, hitting $283.61. The company had a trading volume of 7,457 shares, compared to its average volume of 1,645,002. The stock has a market capitalization of $113.70 billion, a PE ratio of 25.46, a price-to-earnings-growth ratio of 1.85 and a beta of 1.08. Thermo Fisher Scientific Inc. has a twelve month low of $202.83 and a twelve month high of $288.07. The company has a quick ratio of 1.16, a current ratio of 1.69 and a debt-to-equity ratio of 0.61.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Wednesday, April 24th. The medical research company reported $2.81 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.74 by $0.07. The company had revenue of $6.13 billion during the quarter, compared to analysts’ expectations of $6.04 billion. Thermo Fisher Scientific had a net margin of 12.89% and a return on equity of 17.06%. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.50 earnings per share. Equities analysts anticipate that Thermo Fisher Scientific Inc. will post 12.2 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 16th. Stockholders of record on Friday, June 14th will be issued a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 0.27%. The ex-dividend date is Thursday, June 13th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 6.83%.

WARNING: “Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Bought by Swiss National Bank” was originally published by Marea Informative and is the sole property of of Marea Informative. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://www.mareainformativa.com/news/2019/06/12/thermo-fisher-scientific-inc-nysetmo-shares-bought-by-swiss-national-bank.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Featured Story: How do buyers and sellers choose a strike price?

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.